Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease
Friday, November 6, 2020
9:00 AM – 11:00 AM ET
Poster session.
Presentations:
9:00 AM – 11:00 AM ET
Management of Rheumatic Diseases During COVID-19: A National Veterans Affairs Survey of Rheumatologists Jasvinder Singh, MD, MPH – University of Alabama at Birmingham
9:00 AM – 11:00 AM ET
Hydroxychloroquine and Chloroquine and Hospitalizations for Viral Infection in the Pre-COVID-19 Era Sasha Bernatsky, MD, PhD – McGill University
9:00 AM – 11:00 AM ET
Assessing Cytokine Profiles and COVID Serology in Patients on Immunosuppression to Guide Care Recommendations Quinn Pritchett – University of Utah
9:00 AM – 11:00 AM ET
The Impact of the COVID-19 Pandemic on Patients with Chronic Rheumatic Diseases: A Study in 15 Arab Countries Nelly Ziade, MD, PhD – Saint-Joseph University
9:00 AM – 11:00 AM ET
Geographical Variations in COVID-19 Perceptions and Patient Management: A National Survey of Rheumatologists Bella Mehta, MS, MBBS – Hospital for Special Surgery, Weill Cornell Medicine
9:00 AM – 11:00 AM ET
Race/ethnicity Is Associated with Poor Health Outcomes Amongst Rheumatic Disease Patients Diagnosed with COVID-19 in the US: Data from the COVID-19 Global Rheumatology Alliance Physician-Reported Registry Milena A. Gianfrancesco, PhD, MPH – University of California, San Francisco
9:00 AM – 11:00 AM ET
Antimalarial Drug Shortages During the COVID-19 Pandemic: Results from the Global Rheumatology Alliance Patient Experience Survey Emily Sirotich, BSc – McMaster University
9:00 AM – 11:00 AM ET
COVID-19 Infection Among Patients with Rheumatic Disease on Biologic & Targeted Therapies: A Systematic Review Akhil Sood, MD – University of Texas Medical Branch
9:00 AM – 11:00 AM ET
Prevalence of Hydroxychloroquine and Chloroquine Side Effects in Rheumatology Patients: A Retrospective Survey of 115 Cases Zakaria El Ouali, MD – University Hospital of Ibn Rochd
9:00 AM – 11:00 AM ET
Prioritizing Patient Safety While Maintaining Study Integrity During COVID-19: Lupus Intervention Fatigue Trial Modifications and Lessons Learned Dominique Kinnett-Hopkins, PhD – Northwestern University Feinberg School of Medicine
9:00 AM – 11:00 AM ET
Antirheumatic Disease Therapies in Patients with COVID-19: A Systematic Review and Meta-analysis Michael Putman, MD, MSc – The Medical College of Wisconsin
9:00 AM – 11:00 AM ET
Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection Georg Schett, MD – Universitaetsklinikum Erlangen
9:00 AM – 11:00 AM ET
Experiences of Patients with Rheumatic Diseases in the US During the Early Months of the COVID-19 Pandemic Kaleb Michaud, PhD – University of Nebraska Medical Center
9:00 AM – 11:00 AM ET
Colchicine to Weather the Storm in Hospitalized Patients with COVID-19 Luigi Brunetti, PharmD – Rutgers Ernest Mario School of Pharmacy
9:00 AM – 11:00 AM ET
Does the Type of Rheumatic Disease or Biologic Treatment Increase the Risk of Developing Severe COVID-19? Fernando López-Gutierrez, PhD – Rheumatology, Hospital Universitario Ramón y Cajal
9:00 AM – 11:00 AM ET
COVID -19 Lung Inflammation – What Have We Learnt so Far ? Sriya Gokaraju – Southend University Hospital NHS Trust
9:00 AM – 11:00 AM ET
Differential Characteristics in Inflammatory Rheumatologic Patients with Severe and Mild COVID-19 Infection Paula García Escudero, MD – Hospital Universitario Cruces
9:00 AM – 11:00 AM ET
Impact of COVID19 on Missed/Cancelled Rheumatology Office Visits and Parenteral Immunosuppressive Medications Daniel Watrous, MD – Sierra Pacific Arthritis & Rheumatology Centers
9:00 AM – 11:00 AM ET
PROMIS-29 and Health Related Quality of Life in Rheumatology Outpatients During the COVID-19 Pandemic in New York City Gregory J. Vitone, BS – Hospital for Special Surgery
9:00 AM – 11:00 AM ET
Lasting COVID-19 Impacts on US Rheumatology Practices Phil Pouliot, BA, -None- – spherix global insights
9:00 AM – 11:00 AM ET
Characteristics of Rheumatology Outpatients with Suspected or Confirmed COVID-19 During the Pandemic in New York City Medha Barbhaiya, MD, MPH – Hospital for Special Surgery